Skip to main content
Journal cover image

Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions.

Publication ,  Journal Article
Wang, NC; Piccini, JP; Gheorghiade, M
Published in: Heart Fail Rev
September 2011

Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.

Duke Scholars

Published In

Heart Fail Rev

DOI

EISSN

1573-7322

Publication Date

September 2011

Volume

16

Issue

5

Start / End Page

477 / 480

Location

United States

Related Subject Headings

  • Survival Rate
  • Severity of Illness Index
  • Randomized Controlled Trials as Topic
  • Humans
  • Heart Ventricles
  • Heart Rate
  • Heart Failure
  • Electric Countershock
  • Defibrillators, Implantable
  • Death, Sudden, Cardiac
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, N. C., Piccini, J. P., & Gheorghiade, M. (2011). Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. Heart Fail Rev, 16(5), 477–480. https://doi.org/10.1007/s10741-011-9243-5
Wang, Norman C., Jonathan P. Piccini, and Mihai Gheorghiade. “Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions.Heart Fail Rev 16, no. 5 (September 2011): 477–80. https://doi.org/10.1007/s10741-011-9243-5.
Wang NC, Piccini JP, Gheorghiade M. Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. Heart Fail Rev. 2011 Sep;16(5):477–80.
Wang, Norman C., et al. “Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions.Heart Fail Rev, vol. 16, no. 5, Sept. 2011, pp. 477–80. Pubmed, doi:10.1007/s10741-011-9243-5.
Wang NC, Piccini JP, Gheorghiade M. Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. Heart Fail Rev. 2011 Sep;16(5):477–480.
Journal cover image

Published In

Heart Fail Rev

DOI

EISSN

1573-7322

Publication Date

September 2011

Volume

16

Issue

5

Start / End Page

477 / 480

Location

United States

Related Subject Headings

  • Survival Rate
  • Severity of Illness Index
  • Randomized Controlled Trials as Topic
  • Humans
  • Heart Ventricles
  • Heart Rate
  • Heart Failure
  • Electric Countershock
  • Defibrillators, Implantable
  • Death, Sudden, Cardiac